-
nVent Postpones Investor Day Amidst NYC Weather Emergency
nVent Holdings Plc has postponed its Investor Day, originally set for January 16, 2024, due to a severe winter storm and a state of emergency in the New York City area. A new date will be announced soon. The event was planned to discuss strategic priorities, financial outlook, and growth initiatives in key segments like data centers and renewable energy.
-
Trump Demands Netflix Fire Susan Rice Amid DOJ Probe into Warner Deal
Donald Trump has demanded Netflix remove board member Susan Rice, calling her a “political hack” after she suggested Democrats would hold entities accountable for past Trump allegiances. This public spat occurs as Netflix faces intense DOJ scrutiny over its proposed $72 billion acquisition of Warner Bros. Discovery, a deal complicated by a competing bid from Paramount Global and Skydance Media.
-
Princess Cruises Sets Guinness World Record for Most Margaritas Sold in 8 Hours
Princess Cruises set a GUINNESS WORLD RECORDS™ title for the most margaritas sold in eight hours, showcasing their commitment to innovative guest experiences and a vibrant onboard atmosphere. This event highlights their strength in experiential marketing and understanding of the lucrative beverage market within the travel industry. The success underscores efficient operational logistics, consumer engagement, and strategic use of cultural moments to boost brand loyalty and onboard spending.
-
Fuerte’s Coffee Gold Project: Positive PEA Positions Company for Canadian Gold Production
Fuerte Mining’s Coffee Gold Project shows strong potential as a prominent Canadian gold producer, according to a positive Preliminary Economic Assessment (PEA). The study highlights a robust NPV and IRR, projecting over a decade of mine life with excellent gold recovery. Its location in a favorable mining jurisdiction, coupled with resilient economics across various gold price scenarios, enhances its appeal. This PEA marks a key milestone for Fuerte, demonstrating their capability to advance projects and attracting potential investment.
-
Pascal Daloz Assumes Dual Role as CEO and Chairman at Dassault Systèmes
Dassault Systèmes CEO Pascal Daloz now also chairs the board, consolidating leadership. Daloz, leading since 2020, has steered the software firm beyond traditional engineering into life sciences and urban planning. This dual role aims to quicken the rollout of the 3DEXPERIENCE platform, enhancing virtual twin capabilities for innovation. Analysts see this as a move towards unified leadership amid tech shifts, with a focus on AI and simulation for sustainable, intelligent solutions.
-
Three Forces Fueling Wall Street’s Comeback Week
The stock market experienced a rebound last week, with the Nasdaq and S&P 500 posting gains. Major tech stocks surged, fueled by AI demand and increased hyperscaler spending. A Supreme Court ruling against tariffs provided some relief to consumer companies, though impacts on strategy persist. However, concerns in the private credit market, particularly around Blue Owl Capital, led to significant declines for major asset managers, introducing volatility to the financial sector.
-
TREMFYA® (guselkumab) Sustains Clinical and Endoscopic Remission in Ulcerative Colitis Through 3 Years
TREMFYRA® (guselkumab) has shown sustained clinical and endoscopic remission in ulcerative colitis patients over three years. This long-term data highlights the drug’s durability, a key factor in the competitive UC market. As a selective IL-23p19 inhibitor, TREMFYRA® targets inflammation precisely, potentially offering a favorable safety profile for chronic management. These findings strengthen its position as a valuable therapeutic option for moderate to severe UC.
-
Obefazimod Shows Anti-Fibrotic Potential and Enhanced Efficacy in IBD: New Data from ECCO 2026
Abivax presented significant findings on obefazimod at ECCO 2026, revealing its anti-fibrotic activity. Preclinical data demonstrated obefazimod’s potential to combat fibrosis, a key factor in IBD complications. This complements existing clinical data showing efficacy and a favorable safety profile in IBD patients. The dual focus on inflammation and fibrosis positions obefazimod as a potentially transformative therapy for a significant unmet need.
-
My Experience at India’s AI Summit
India’s AI Impact Summit faced logistical issues and controversies, including Bill Gates’ withdrawal and a robot dog dispute. Despite disorganization, U.S. tech giants like Google and OpenAI reaffirmed their commitment to India’s AI market, drawn by its talent and consumer base. The government aims to attract $200 billion in AI investments, highlighting India’s continued importance as a growth frontier for global tech firms, even with occasional turbulence.
-
Tech Giants Pledge Hundreds of Billions to Fuel India’s AI Boom
Tech giants are significantly increasing AI investments in India, with billions pledged by hyperscale cloud providers and domestic conglomerates for data centers and infrastructure. This surge aligns with India’s ambition to become a tech powerhouse, fostering deeper U.S.-India economic ties. While acknowledging India’s engineering talent, some analysts note a lag in private capital and suggest a focus on foundational challenges.
